Catalent (CTLT) Tops Q4 EPS by 7c, Revenues Miss; Offers FY19 Revenue Outlook Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Catalent, Inc. Reports Fourth Quarter Fiscal 2018 Results
August 28, 2018 7:30 AM EDTQ4'18 revenue of $685.3 million increased 11% as-reported, or 9% in constant currency from the prior-year period. Full-year revenue of $2,463.4 million increased 19% as-reported, or 16% in constant currency from the prior-year. Closed the acquisition of Juniper Pharmaceuticals, a European early development Center of Excellence with dose form development and clinical manufacturing capabilities. Issued 11,431,411 shares of common stock at a price to the public of $40.24, raising approximately $445 million of net proceeds used to pay down USD Term Loan floating-rate debt.... More
